Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Karpiak

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Computational Chemistry|July 2, 2009
Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptorSantiago Vilar, Joel Karpiak, Stefano Costanzi
Journal of Molecular Graphics & Modelling|February 22, 2011
In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptorSantiago Vilar, Joel Karpiak, Barkin Berk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Quantification of the transferability of a designed protein specificity switch reveals extensive epistasis in molecular recognitionCristina Melero, Noah Ollikainen, Ian Harwood, et al.
Journal of Medicinal Chemistry|October 8, 2015
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based DockingT Justin Rettenmaier, Hao Fan, Joel Karpiak, et al.
Bioorganic & Medicinal Chemistry|October 28, 2009
Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholaminesChaya Pooput, Erica Rosemond, Joel Karpiak, et al.
Nature Chemical Biology|June 1, 2010
Structural basis of G protein-coupled receptor-G protein interactionsJianxin Hu, Yan Wang, Xiaohong Zhang, et al.
Scientific Reports|June 6, 2018
Author Correction: Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxesEmir Salas-Sarduy, Lionel Urán Landaburu, Joel Karpiak, et al.
Journal of Medicinal Chemistry|July 11, 2018
Selectivity Challenges in Docking Screens for GPCR Targets and AntitargetsDahlia R Weiss, Joel Karpiak, Xi-Ping Huang, et al.
Scientific Reports|September 23, 2017
Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxesEmir Salas-Sarduy, Lionel Urán Landaburu, Joel Karpiak, et al.
Journal of Medicinal Chemistry|October 16, 2010
Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitorsOliv Eidam, Chiara Romagnoli, Emilia Caselli, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Computational Chemistry|July 2, 2009
Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptorSantiago Vilar, Joel Karpiak, Stefano Costanzi
Journal of Molecular Graphics & Modelling|February 22, 2011
In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptorSantiago Vilar, Joel Karpiak, Barkin Berk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Quantification of the transferability of a designed protein specificity switch reveals extensive epistasis in molecular recognitionCristina Melero, Noah Ollikainen, Ian Harwood, et al.
Journal of Medicinal Chemistry|October 8, 2015
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based DockingT Justin Rettenmaier, Hao Fan, Joel Karpiak, et al.
Bioorganic & Medicinal Chemistry|October 28, 2009
Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholaminesChaya Pooput, Erica Rosemond, Joel Karpiak, et al.
Nature Chemical Biology|June 1, 2010
Structural basis of G protein-coupled receptor-G protein interactionsJianxin Hu, Yan Wang, Xiaohong Zhang, et al.
Scientific Reports|June 6, 2018
Author Correction: Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxesEmir Salas-Sarduy, Lionel Urán Landaburu, Joel Karpiak, et al.
Journal of Medicinal Chemistry|July 11, 2018
Selectivity Challenges in Docking Screens for GPCR Targets and AntitargetsDahlia R Weiss, Joel Karpiak, Xi-Ping Huang, et al.
Scientific Reports|September 23, 2017
Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxesEmir Salas-Sarduy, Lionel Urán Landaburu, Joel Karpiak, et al.
Journal of Medicinal Chemistry|October 16, 2010
Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitorsOliv Eidam, Chiara Romagnoli, Emilia Caselli, et al.
Pageof 2